Click on image to view larger version.
Figure 5 Changes in the in vitro MVO2 by bradykinin and sodium nitroprusside 24 h after sham surgery or CS. (Left) The effect of 10–4 mol/l L-NAME on the in vitro MVO2 changes by bradykinin and sodium nitroprusside in the sham group with NCD and HCD. (Right) The effect of BH4 on those in the CS groups with NCD and HCD (n = 7 in each group for Bonferroni’s post-hoc comparisons). *p < 0.01 vs. baseline; 
p < 0.01 vs. NCD-sham; 
p < 0.05 HCD-CS vs. NCD-CS. P < 0.05 NCD-CS + BH4 vs. NCD-CS; p < 0.01 HCD-CS + BH4 vs. HCD-CS (asterisks not shown on right panel). BK = bradykinin; SNP = sodium nitroprusside; other abbreviations as in Figures 1 and 4.